TUC338 Promotes Diffuse Large B Cell Lymphoma Growth via Regulating EGFR/PI3K/AKT Signaling Pathway.

Li, Yan; Jia, Zhenwei; Zhao, Hongbo; Liu, Xiaoyan; Luo, Jianmin; Cui, Guirong; Kong, Xiaoyang

Li, Yan; Jia, Zhenwei; Zhao, Hongbo; Liu, Xiaoyan; Luo, Jianmin; Cui, Guirong; Kong, Xiaoyang.

Afiliação

Li Y; Department of Hematology, Handan First Hospital, Handan, Hebei 056002, China.
Jia Z; Department of Hematology, Handan First Hospital, Handan, Hebei 056002, China.
Zhao H; Department of Hematology, Handan First Hospital, Handan, Hebei 056002, China.
Liu X; Department of Hematology, Handan First Hospital, Handan, Hebei 056002, China.
Luo J; Department of Hematology, Handan First Hospital, Handan, Hebei 056002, China.
Cui G; Department of Hematology, Handan First Hospital, Handan, Hebei 056002, China.
Kong X; Department of Hematology, Handan First Hospital, Handan, Hebei 056002, China.

J Oncol ; 2021: 5593720, 2021.

Article em En | MEDLINE | ID: mdl-33986803

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: J Oncol Ano de publicação: 2021 Tipo de documento: Article País de afiliação: China País de publicação: Egito

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google